Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exicure (XCUR) Research & Development (2016 - 2025)

Exicure (XCUR) has disclosed Research & Development for 9 consecutive years, with $888000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development changed N/A year-over-year to $888000.0, compared with a TTM value of $2.6 million through Sep 2025, changed N/A, and an annual FY2023 reading of $1.4 million, down 92.8% over the prior year.
  • Research & Development was $888000.0 for Q3 2025 at Exicure, down from $935000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $16.5 million in Q3 2021 and bottomed at $808000.0 in Q1 2025.
  • Average Research & Development over 4 years is $6.1 million, with a median of $5.8 million recorded in 2022.
  • The sharpest move saw Research & Development skyrocketed 80.07% in 2021, then plummeted 90.6% in 2022.
  • Year by year, Research & Development stood at $11.4 million in 2021, then tumbled by 90.6% to $1.1 million in 2022, then skyrocketed by 32.62% to $1.4 million in 2023, then plummeted by 37.6% to $888000.0 in 2025.
  • Business Quant data shows Research & Development for XCUR at $888000.0 in Q3 2025, $935000.0 in Q2 2025, and $808000.0 in Q1 2025.